Strategic Operations, Inc. v. Joseph et al
Filing
15
ORDER Granting Defendants' 10 Motion to Dismiss for Failure to State a Claim. Signed by Judge Janis L. Sammartino on 8/13/2018. (mpl)
1
2
3
4
5
6
7
8
9
UNITED STATES DISTRICT COURT
10
SOUTHERN DISTRICT OF CALIFORNIA
11
12
STRATEGIC OPERATIONS, INC.,
Case No.: 17-CV-1539-JLS (NLS)
Plaintiff,
13
14
v.
ORDER GRANTING DEFENDANTS’
MOTION TO DISMISS
15
BREA K. JOSEPH, et al.,
(ECF No. 10)
Defendants.
16
17
18
Presently before the Court is Defendants Brea K. Joseph and KBZ FX, Inc.’s Motion
19
to Dismiss, (“MTD,” ECF No. 10). Also before the Court is Plaintiff Strategic Operations,
20
Inc.’s Response in Opposition to the Motion, (“Opp’n,” ECF No. 11), and Defendants’
21
Reply in Support of the Motion, (“Reply,” ECF No. 13). The Court vacated oral argument
22
on the Motion and took the matter under submission without oral argument. (ECF No. 12.)
23
After considering the Parties’ arguments and the law, the Court rules as follows.
BACKGROUND
24
25
Plaintiff Strategic Operations, Inc. (“StOps”) filed a Complaint against Brea Joseph,
26
Kasey Erokhin, KBZ FX, and KBX FX, Inc. (“Compl.,” ECF No. 1.) Plaintiff brings
27
causes of action of patent infringement, breach of nondisclosure agreement, and unfair
28
competition.
1
17-CV-1539-JLS (NLS)
1
Plaintiff is the executive licensee of United States Patent No. 8,840,403 (“the ’403
2
patent”). (Id. ¶ 17.) The ’403 patent “pertains to devices and methods for simulating
3
realistic-looking, dynamic injuries that a person may receive during a traumatic event.”
4
(Id. ¶ 18.) For example, the devices claimed in the patent “can be worn by ‘role players’
5
during a simulated traumatic event to mimic a plurality of different combat-related
6
bleeding wounds and internal injuries and allow first responders to perform medical
7
treatment on the same.” (Id.)
8
Defendants Joseph and Erokin were previously employed by Plaintiff as injury
9
simulation makeup artists. (Id. ¶ 19.) During their employment, Joseph and Erokin were
10
exposed to role players wearing and using the “Cut Suit,” which is one of Plaintiff’s human-
11
worn trauma and medical training products. (Id. ¶¶ 19–20.) The “Cut Suit” embodies or
12
uses one or more inventions claimed in the ’403 patent. (Id. ¶ 19.) Plaintiff previously
13
sued Joseph and Erokin for breach of loyalty, interference with employment relationship,
14
and violation of the Uniform Trade Secrets Act. (Id. ¶ 22.) As part of the settlement
15
agreement in that case, “Joseph and Erokhin agreed to refrain from using Strategic
16
Operations’ confidential and proprietary technology and trade secret information for any
17
purpose.” (Id. ¶ 23.)
18
In June 2011, Joseph and Erokin left Plaintiff’s company and formed KBZ FX which
19
is “a special effects medical training support system,” which provides “injury simulations.”
20
(Id. ¶ 24.) One of KBZ FX’s products is a “trauma training kit” (hereinafter, “TTK”),
21
which is “a human body replica suit used to perform actual treatments on for medical
22
training.” (Id. ¶ 25.) Plaintiff alleges the TTK infringes the ’403 patent. Plaintiff also
23
brings causes of action for breach of nondisclosure agreement and unfair competition.
24
Finally, Plaintiff alleges Defendants have failed to respect the corporate form of KBZ FX.
25
Defendants Joseph and KBZ FX, Inc. move to dismiss Plaintiff’s infringement claim
26
27
28
and alter ego allegations pursuant to Federal Rule of Civil Procedure 12(b)(6).
LEGAL STANDARD
Federal Rule of Civil Procedure 12(b)(6) permits a party to raise by motion the
2
17-CV-1539-JLS (NLS)
1
defense that the complaint “fail[s] to state a claim upon which relief can be granted,”
2
generally referred to as a motion to dismiss. The Court evaluates whether a complaint
3
states a cognizable legal theory and sufficient facts in light of Federal Rule of Civil
4
Procedure 8(a), which requires a “short and plain statement of the claim showing that the
5
pleader is entitled to relief.”
6
allegations,’ . . . it [does] demand more than an unadorned, the-defendant-unlawfully-
7
harmed-me accusation.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl.
8
Corp. v. Twombly, 550 U.S. 544, 555 (2007)). In other words, “a plaintiff’s obligation to
9
provide the ‘grounds’ of his ‘entitle[ment] to relief’ requires more than labels and
10
conclusions, and a formulaic recitation of the elements of a cause of action will not do.”
11
Twombly, 550 U.S. at 555 (citing Papasan v. Allain, 478 U.S. 265, 286 (1986)). A
12
complaint will not suffice “if it tenders ‘naked assertion[s]’ devoid of ‘further factual
13
enhancement.’” Iqbal, 556 U.S. at 677 (citing Twombly, 550 U.S. at 557).
Although Rule 8 “does not require ‘detailed factual
14
In order to survive a motion to dismiss, “a complaint must contain sufficient factual
15
matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Id. (quoting
16
Twombly, 550 U.S. at 570); see also Fed. R. Civ. P. 12(b)(6). A claim is facially plausible
17
when the facts pled “allow the court to draw the reasonable inference that the defendant is
18
liable for the misconduct alleged.” Iqbal, 556 U.S. at 677 (citing Twombly, 550 U.S. at
19
556). That is not to say that the claim must be probable, but there must be “more than a
20
sheer possibility that a defendant has acted unlawfully.” Id. Facts “‘merely consistent
21
with’ a defendant’s liability” fall short of a plausible entitlement to relief. Id. (quoting
22
Twombly, 550 U.S. at 557). Further, the Court need not accept as true “legal conclusions”
23
contained in the complaint. Id. This review requires context-specific analysis involving
24
the Court’s “judicial experience and common sense.” Id. at 678 (citation omitted).
25
“[W]here the well-pleaded facts do not permit the court to infer more than the mere
26
possibility of misconduct, the complaint has alleged—but it has not ‘show[n]’—‘that the
27
pleader is entitled to relief.’” Id.
28
///
3
17-CV-1539-JLS (NLS)
1
2
ANALYSIS
I.
Patent Infringement
3
Plaintiff attached as an exhibit to its Complaint screenshots of KBZ FX’s website.
4
The first image is one of a skeleton with “TTK: Trauma Training Kit” written on top of the
5
image. (Compl. 29.)1 The text above the image provides:
Introducing KBZ FX’s Trauma Training Kit (TTK). The TTK is an effective
and economical way to train your First Responders, Medical Professionals,
and Combat Medics on live Role Players. In the past, in-field medical
procedure training has been limited to practicing on rescue dummies and
mannequins with limited audio and visual feedback resulting in a lack of
realism. The TTK is a wearable chest prosthetic as well as a line of limb
attachments that are worn by a live person that can give immediate realistic
feedback in real time training scenarios.
Please contact us
(KBZFXmakeup1@gmail.com) for options and pricing.
6
7
8
9
10
11
12
13
(Id.) Below are more images of products, which appear to be part of the TTK. These
14
images include an image of a “skin vest,” an image of “rib cage and organs” depicting
15
simulated organs, followed by multiple other images of “attachments” which are products
16
for all body parts. (Id. at 30–43.)
17
Defendants’ main argument is that these images from the website do not depict a
18
product made, used or sold by KBZ but reflect “old marketing materials that were briefly
19
posted on KBZ’s website from January through April[] 2017 purely for marketing
20
purposes.” (MTD 6.) KBZ’s actual product “lacks an outer raiment having at least one
21
fluid reservoir (as required by the ’403 patent) and lacks a cavity for containing prosthetic
22
internal human organs (as required by the ’403 patent).” (Id. at 6–7.) For these reasons,
23
Defendants argue they do not infringe the ’403 patent.
A. Attached Declarations
24
25
Defendants state they have never sold or offered for sale any infringing product, and
26
include declarations by Ms. Joseph to this effect. (ECF Nos. 10-2; 13-1.) In a footnote,
27
28
1
Pin citations refer to the CM/ECF page numbers electronically stamped at the top of each page.
4
17-CV-1539-JLS (NLS)
1
Defendants ask the Court to consider the declarations when analyzing the motion to
2
dismiss. (MTD 6 n.1.)
3
As a general rule, “a district court may not consider any material beyond the
4
pleadings in ruling on a Rule 12(b)(6) motion.” Lee v. City of Los Angeles, 250 F.3d 668,
5
688 (9th Cir. 2001). The only exceptions to this rule are for (1) material which is submitted
6
with or necessarily relied on in the complaint and (2) matters of public record. Id. at 688–
7
89. The attached declarations are not pleadings, see Fed. R. Civ. P. 7(a), were not attached
8
to or relied on in the Complaint, nor are they a matter of public record. To consider the
9
declarations would convert the Motion to Dismiss into a motion for summary judgment,
10
and the Court declines to do so at this stage. Therefore, the Court cannot consider the
11
declarations here.2 See Cooper v. Pickett, 137 F.3d 616, 623 (9th Cir. 1997) (refusing to
12
consider declarations submitted in support of a motion to dismiss because they were not
13
“referenced in the complaint” or matters of public record).
B. “Offer for Sale” Analysis
14
15
An act of direct patent infringement occurs when an entity “without authority makes,
16
uses, offers to sell, or sells any patented invention, within the United States or imports into
17
the United States any patented invention during the term of the patent.” 35 U.S.C. § 271(a).
18
The issue here is whether Plaintiff has sufficiently alleged Defendants offered for sale an
19
infringing product. The statute broadly defines “offer for sale” or “offer to sell” as “that in
20
which the sale will occur before the expiration of the term of the patent.” 35 U.S.C.
21
§ 271(i). The Federal Circuit has held an “offer to sell” occurs when the alleged infringer
22
sends “a description of the allegedly infringing merchandise and the price at which it can
23
be purchased.” 3D Sys., Inc. v. Aarotech Labs, Inc., 160 F.3d 1373, 1379 (Fed. Cir. 1998).
24
The Federal Circuit later revisited the issue and defined “‘offer to sell’ liability according
25
26
For the same reasons, the Court does not consider the declaration and exhibits attached to Plaintiff’s
Opposition. (ECF No. 11-1.) See also Frenzel v. AliphCom, 76 F. Supp. 3d 999, 1009 (N.D. Cal. 2014)
(noting that “[i]t is axiomatic that the complaint may not be amended by the briefs in opposition to a
motion to dismiss”).
2
27
28
5
17-CV-1539-JLS (NLS)
1
to the norms of traditional contractual analysis.” Rotec Indus., Inc. v. Mitsubishi Corp.,
2
215 F.3d 1246, 1254–55 (Fed Cir. 2000). The next year, the Federal Circuit reaffirmed
3
this general definition after interpreting the Supreme Court’s opinion in Pfaff v. Wells
4
Electronics, Inc., 525 U.S. 55 (1998). See Group One, Ltd. v. Hallmark Cards, Inc., 254
5
F.3d 1041, 1046 (Fed. Cir. 2001). The court held the language from Pfaff “strongly
6
suggests that the offer must meet the level of an offer for sale in the contract sense, one
7
that would be understood as such in the commercial community. Such a reading leaves no
8
room for ‘activity which does not rise to the level of a formal “offer” under contract law
9
principles.’” Id. at 1046–47. The court “note[d] in passing that contract law traditionally
10
recognizes that mere advertising and promoting of a product may be nothing more than an
11
invitation for offers, while responding to such an invitation may itself be an offer.” Id. at
12
1048 (citing Restatement (Second) of Contracts § 26 (1981)).
13
Here, accepting all Plaintiff’s allegations as true, and even disregarding Defendants’
14
declarations, the Court finds the posting of TTK, as depicted exhibit 2 to the Complaint, is
15
not an “offer for sale.” There is no information on pricing of the product; instead the post
16
specifically invites the consumer to send an email to request pricing information. This is
17
merely an “invitation for offers.” Id. The posting is not sufficiently alleged to be an “offer
18
for sale.”
19
The Complaint specifically alleges “[d]espite being informed of StOps’ ’403 Patent
20
and StOps concerns that the TTK infringes the ‘403 Patent, Joseph, Erokhin, KBZ FX, and
21
now KBZ FX, INC. nevertheless continue to make, use, sell, and offer for sale, the TTK.”
22
(Compl. ¶ 29.) But this is merely a conclusory allegation, and, without the attached exhibit,
23
has no support.3 Because Plaintiff has failed to sufficiently plead an element of patent
24
infringement, the Court GRANTS Defendants’ Motion to Dismiss this claim.
25
26
3
27
28
Further, Defendants admit they do make a product, which is not the product depicted on the website
(TTK), but argue that it is not infringing. (MTD 6 (referring to “the actual KBZ product”).) Plaintiff has
not alleged that this product is sold or offered for sale by Defendants, thus the Court does not analyze this
unspecified product.
6
17-CV-1539-JLS (NLS)
1
2
3
4
5
6
7
8
9
10
II.
Alter Ego Allegations
Plaintiff alleges:
On information and belief, Defendants Erokhin, Joseph, KBZ
FX, and KBZ FX, Inc., and each of them, among other things:
(a) commingled funds and other assets; (b) treated corporate
assets as personal assets; (c) failed to observe corporate
formalities and adhere to corporate bylaws; (d) used the
corporate structure as a subterfuge for illegal transactions; and
(e) were undercapitalized; and, therefore, there exists a unity of
interest and ownership between each of these named Defendants
such that Defendant KBZ FX, Inc. is the Alter Ego of Defendants
Erokhin, Joseph, KBZ FX and that any separateness between
them has ceased to exist and that to adhere to the fiction of their
separate identities would result in injustice.
11
12
(Compl. ¶ 9.) Defendants move to dismiss these allegations because they are not pled with
13
particularity. (MTD 8.)
14
“Conclusory allegations of ‘alter ego’ status are insufficient to state a claim.”
15
Neilson v. Union Bank of Cal., N.A., 290 F. Supp. 2d 1101, 1116 (C.D. Cal. 2003). “Rather,
16
a plaintiff must allege specifically both the elements of alter ego liability, as well as facts
17
supporting each.” Id. These elements are: “(1) such a unity of interest and ownership
18
exists that the personalities of the corporation and individual are no longer separate, and
19
(2) an inequitable result will follow if the acts are treated as those of the corporation alone.”
20
RRX Indus., Inc. v. Lab–Con, Inc., 772 F.2d 543, 545–46 (9th Cir. 1985). In analyzing the
21
doctrine, courts consider factors such as:
22
23
24
25
commingling of funds and other assets of the two entities, the
holding out by one entity that it is liable for the debts of the other,
identical equitable ownership in the two entities, use of the same
offices and employees, and use of one as a mere shell or conduit
for the affairs of the other.
26
Sonora Diamond Corp. v. Superior Court, 83 Cal. App. 4th 523, 538–39 (Ct. App. 2000)
27
(internal quotations omitted).
28
For the first alter ego element, Plaintiff merely alleges the basic Sonora factors:
7
17-CV-1539-JLS (NLS)
1
mixing funds, lack of corporate formalities, and undercapitalization.
2
Plaintiff provides no facts in support of these allegations. For the second alter ego element,
3
Plaintiff alleges “to adhere to the fiction of [Defendants’] separate identities would result
4
in injustice.” (Compl. ¶ 9.) Again, this is conclusory, has no support, and Plaintiff has not
5
alleged how or why injustice would result if the corporate veil is not pierced. It is also
6
unclear to which cause of action the alter ego allegations apply, and why piercing the
7
corporate veil is necessary for an equitable result. Plaintiff has not sufficiently pled either
8
element of alter ego and the Court GRANTS Defendants’ Motion to Dismiss the alter ego
9
allegations.
10
(Compl. ¶ 9.)
CONCLUSION
11
For the foregoing reasons, the Court GRANTS Defendants’ Motion to Dismiss. The
12
Court GRANTS Plaintiff leave to amend its Complaint. Plaintiff MAY file an amended
13
complaint on or before thirty (30) days of the electronic docketing of this Order. Should
14
Plaintiff choose not to file an amended complaint by this time, this case will proceed on
15
the remaining allegations.
16
17
IT IS SO ORDERED.
Dated: August 13, 2018
18
19
20
21
22
23
24
25
26
27
28
8
17-CV-1539-JLS (NLS)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?